Ju Teng International Holdings Limited Overview
Ju Teng is a Taiwanese-managed, Hong Kong-listed contract manufacturer of notebook-computer and 2-in-1 casings. Through the late 2000s and 2010s it described itself as holding more than 30% of the global notebook-casing market. It is a component supplier to the Taiwanese ODM ecosystem, including Compal, Wistron and other large ODMs and brands. It has full process breadth across mould-making, plastic injection, magnesium-aluminium die-casting, metal stamping, CNC machining, composites, anodizing and surface finishing.
The business peaked with pandemic-era revenue of HK$11.3 billion in FY2021. It has since shrunk by roughly half as notebook demand normalised, tariffs pushed ODM assembly out of China, and Ju Teng's China-heavy footprint became stranded. The company has reported losses for three consecutive years (FY2023–FY2025), and the H1 2026 loss of HK$813 million was severe.
It is now mid-way through a capacity migration to Vietnam and is the subject of a conditional change-of-control. Lens Technology has agreed to buy the founding Cheng family's 27.81% and plans a general offer at HK$2.20 per share.
Company's own description. The FY2025 annual report and FY2026 interim report describe Ju Teng in consistent terms:
-
It is an investment holding company whose subsidiaries manufacture and sell casings for notebook computers and handheld devices.
-
Notebook computer casings and 2-in-1 computer casings remain its core products and main revenue source.
-
It positions itself as one of the world's leading notebook casing manufacturers, with long-standing relationships across its upstream and downstream supply chain.
The FY2025 chairman's statement sets out four priorities:
-
strengthening the group's ability to win orders in higher-value areas such as high-end metal casings;
-
following the "high-end casing and AI PC" trend;
-
consolidating domestic (PRC) factories;
-
accelerating capacity ramp-up in Vietnam.
Business model. Ju Teng is a build-to-order, project-based component manufacturer:
Revenue recognition: 100% of revenue is "sale of casings for notebook computer and handheld devices", recognised at a point in time on delivery. Payment terms are generally 60–120 days (FY2025 results, note 3).
Contracts: Customers buy by individual purchase order. The group has no long-term sales contracts with any major customer (AR2025, "Relationships with key stakeholders").
Revenue mix: Effectively 100% product revenue. There is no subscription, licensing or service revenue of any significance. Rental, subsidy and compensation income are booked below gross profit in "other income".
Value chain position: Tier-1 mechanical-component supplier. Ju Teng sells casings (lid/A-cover, bezel/B-cover, palm-rest/C-cover and bottom/D-cover sets, plus 2-in-1 enclosures) to ODMs and brand owners, who integrate them into finished notebooks. Delivery-location data show this geographically: most revenue is "delivered to" mainland China, where ODM final assembly historically sat. Vietnam emerged as a delivery destination in 2025–2026.
Embedded ODM partnerships: Ju Teng co-owns subsidiaries with its two most important ODM customers:
-
Wistron is a substantial shareholder of Mindforce Holdings Limited, a non-wholly-owned Ju Teng subsidiary.
-
Compal is a substantial shareholder of Wah Yuen Technology Holding Limited, another non-wholly-owned subsidiary.
-
Sales to both are disclosed continuing connected transactions under three-year master sales agreements running to 31 Dec 2026 (AR2025, Report of the Directors).
Customer types and concentration (FY2025, AR2025):
-
Five largest customers: about 81% of revenue.
-
Largest customer: about 22%.
-
Five largest suppliers: below 30% of purchases.
-
Four customer groups each exceeded 10% of revenue in FY2025: HK$1,268.8m, HK$1,223.6m, HK$1,100.4m and HK$660.8m.
-
The third and fourth match the disclosed connected-transaction sales to the Compal Group (HK$1,100.4m) and the Wistron Group (HK$660.8m).
End-markets served:
-
Notebook PCs, both consumer and commercial (core).
-
2-in-1/convertible PCs.
-
Handheld devices.
-
Historically, TV casings and "customised products" (third-party profile).
-
Small and emerging: automotive parts and electric-bicycle components. These are cited in the FY2025 biography of the senior manager running Compal Precision Module (Jiangsu) and in the Vietnam strategy, which names "notebook casings and automotive parts".
Independent characterisation. Ju Teng is a scale manufacturer with high fixed costs in a commoditised, cyclical, customer-concentrated niche. Key features:
High operating leverage: Depreciation alone was HK$573m in FY2025, about 10% of revenue. When utilisation falls, gross margin collapses: from 10.7% in FY2021 to 2.9% in FY2024. In H1 2026, HK$510m of idle-capacity cost was moved out of cost of sales into "other expenses".
Structural FX mismatch: Revenue is mainly in US$, costs mainly in RMB, and borrowings mainly in US$. Renminbi appreciation directly hurts reported earnings: FX losses were HK$105m in FY2025 and HK$211m in H1 2026.
Strategic problem: This is geographic, not technological. Notebook ODMs are relocating assembly to Southeast Asia because of US tariffs, and Ju Teng's asset base was about 79% PRC by non-current assets at end-2025. The group has been monetising PRC land through government resumptions and disposals while building in Vietnam.
Shareholding structure: It is unusual: a share-award trust holds 29.53% of the equity and a founder trust holds 25.27%. That structure largely determines the outcome of the Lens Technology offer.
Strategy
Stated strategy (themes paraphrased from AR2025 chairman's statement and MD&A, and Interim Report 2026)
-
Capacity reconfiguration. Integrate and shrink PRC factories, ramp Vietnam, and build cross-regional production collaboration, so that production is more efficient, flexible and lower cost.
-
Product upgrading. Develop and apply new products, optimise the casing portfolio, and win more high-value orders, explicitly high-end metal casings.
-
AI PC and Windows refresh positioning. Track AI PC technology roadmaps and the Windows 10 to 11 replacement cycle, and coordinate R&D and production resources around them.
-
Cost and efficiency. Prudent operations, cost reduction, flexible pricing, and periodic review of asset-optimisation plans.
-
Diversification. Widen the product mix and look for new customers to reduce product and customer concentration (risk section).
Strategic initiatives, last 24 months (Oct 2024 – Oct 2026)
| Date | Initiative | Detail / target | Source |
|---|---|---|---|
| Oct–Nov 2024 | Vietnam equipment procurement | Discloseable procurement contracts for Vietnam plant equipment, including with Shenzhen Huahaida | Announcement index 2024 |
| Dec 2024 | Wujiang land resumption completion (part) | Certain disposals completed; others postponed | Announcement 27 Dec 2024 |
| Q2 2025 | Vietnam plant starts production | Ramp continuing; H1 2026 Vietnam-delivered revenue HK$266m | AR2025; Interim Report 2026 |
| 16 Apr 2025 | Zhongshan asset monetisation | RMB145m; up to three years to vacate, timed with expected relocation of local brand customers | Announcement 16 Apr 2025 |
| 12 May 2025 | Dachang II resumption re-papered | RMB356.3m from the local authority; vacate by 30 Mar 2027 | Announcement 12 May 2025 |
| 28 May 2025 | 2025 Share Option Scheme | Mandate of 120,000,844 shares (10%); no grants yet | AR2025 |
| 11 Jun 2025 | Lens-linked executive appointment | Wang Ting Jin appointed executive director | AR2025 |
| Jan–Feb 2026 | Cybersecurity remediation | Firewall upgrade, jump servers, least-privilege remote access | Announcement 12 Feb 2026 |
| Mar 2026 | Syndicated loan First Amendment | Interest-coverage waivers for FY2025 and H1 2026; revised tangible-net-worth and gearing covenants | FY2025 results |
| 15 Apr 2026 | Share Award Plan revised | Allows trust shares to accept a general offer (Lens SPA CP1, satisfied) | Joint Announcement 18 May 2026 |
| H1 2026 | New-product trial production | Trial-production costs reclassified to selling expenses (part of the HK$73m rise in S&D) | Interim Report 2026 |
| 2026–2027 | Lens integration (pending) | Lens to review operations; may consider asset acquisitions or disposals, restructuring or fund-raising | Joint Announcement 18 May 2026 |
Medium-term targets and guidance
-
No quantitative revenue, margin or capex targets have been published in the filings reviewed. Outlook language is qualitative: "prudently optimistic" (AR2025) and "consistent prudent operating approach" (Interim Report 2026).
-
ESG or sustainability commitments with numeric targets: not disclosed in the materials reviewed. ESG reports are published separately.
Products & Services
Ju Teng does not publish a product catalogue, price list or named product brands. Products are customer-specific casings made to ODM and brand designs. The catalogue below is reconstructed from filings, process disclosures and management biographies. Pricing is quoted per project and per purchase order and is not publicly disclosed.
Revenue by product line is not publicly disclosed. Filings report a single revenue line.
Product Portfolio
| Product / capability line | Description and key specifications | Target customer | Launch / latest reference | Pricing model | Named flagships | Source |
|---|---|---|---|---|---|---|
Notebook casings (plastic) | Injection-moulded A/B/C/D covers; two-colour and high-temperature moulds; in-mould decoration (IMD), which bonds decorative film to plastic during moulding | Notebook ODMs (Compal, Wistron, Quanta, Asustek, Inventec historically) and brand owners | Core since 2001; IMD cited in AR2006 | Per-order, project pricing; not disclosed | — | AR2006; AR2025 senior-management profile |
2-in-1 / convertible casings | Enclosures for detachable and convertible PCs | Same | Cited as core in AR2023–AR2025 | Per-order | — | AR2025 |
Metal notebook casings (aluminium) | CNC-machined and stamped aluminium shells; anodizing at the Taizhou plant (set up 2017) | Premium and commercial notebook programmes | Strategic focus in AR2025 ("high-end metal casings") | Per-order | — | irasia profile; AR2025 |
Magnesium-aluminium alloy casings | Die-casting and thixomolding; magnesium-aluminium process and mould design | Lightweight and premium notebooks | Ongoing; run at Compal Precision Module (Jiangsu) | Per-order | — | AR2025 senior-management profile |
Composite / carbon-fibre casings | Carbon-fibre and glass-fibre composite covers using RocTool rapid heat-cycle moulding; carbon-fibre alloy casing launched in 2005 | Ultralight notebooks, smartphones (licensed) | 2005 launch; 2013 composite factory (around 100 RocTool-equipped lines); 2014 licences | Per-order; RocTool licence fees paid by Ju Teng | — | AR2005; RocTool release 2014 |
Handheld device casings | Casings for handheld and mobile devices | Device OEMs/ODMs | Part of reported segment description | Per-order | — | Results announcements |
Surface finishing and coating | Spray painting, hot stamping, decorative and surface-treatment NPI | Embedded in casing programmes | Ongoing | Bundled in casing price | — | AR2025 senior-management profiles |
Mould design and making | Plastic, metal, high-temperature and two-colour moulds; in-house since 2004 | Internal; supports NPI | Ongoing | Bundled | — | irasia profile; AR2025 |
Automotive parts | Magnesium-aluminium and other structural parts; Vietnam earmarked for "notebook casings and automotive parts" | Automotive tier suppliers (not named) | Emerging (cited AR2025) | — | — | AR2025 risk section; senior-management profile |
Electric-bicycle components | Magnesium-aluminium components | E-bike OEMs (not named) | Emerging | — | — | AR2025 senior-management profile |
Materials and peripherals trading | Sale of materials, computer equipment and peripherals, casing-related materials | Customers and affiliates | Minor | — | — | Third-party company profile (S&P-sourced) |
TV and "customised product" casings | Historical lines | Consumer electronics brands | Historical; not cited in recent filings | — | — | Third-party profile |
“—” = not publicly disclosed.
Financial Narrative
All figures in HK$ millions unless stated. Sources are the FY2022, FY2023, FY2024 and FY2025 annual results announcements (audited consolidated statements, with FY2021 taken from the FY2022 comparatives) and AR2025 financial highlights.
Income statement
EBITDA here is calculated. It reconciles to company-reported EBITDA of HK$130m (FY2024) and HK$106m (FY2025) in AR2025. It includes impairments and one-off gains.
Margins and growth
Revenue CAGR FY2021–FY2025: -15.6% a year (HK$11,283m to HK$5,731m). Calculated.
Material non-recurring items embedded in results
Sources: notes to FY2022–FY2025 results announcements.
-
FY2023 disposal gains net a HK$2.3m PP&E loss and a HK$1.0m held-for-sale loss. They exclude a HK$42.5m gain on disposal of a subsidiary.
-
FY2025 disposal gains are HK$85.3m on PP&E/ROU plus HK$142.7m on held-for-sale assets. A further HK$16.1m deregistration gain is excluded.
-
Positive inventory figures are reversals.
Commentary – income statement. The five-year arc has three phases.
FY2021: pandemic peak: Revenue reached HK$11.3bn, but gross margin had already fallen from 14.3% in FY2020 to 10.7% (FY2021 results), as input and labour costs rose ahead of pricing.
FY2022–FY2023: demand collapse, cushioned by one-offs: Revenue fell 26.8% and then 16.0% as global PC shipments dropped by 16.2% (2022) and 14.8% (2023), per Gartner as cited by the company. Reported profit in FY2022 (HK$172m attributable) was almost entirely non-operating: HK$525m of Suzhou relocation compensation and HK$395m of FX gains offset an operating loss and HK$338m of impairments. FY2023 gross margin recovered to 7.3% on capacity cuts and product mix. However, three things produced the first attributable loss (HK$231m):
-
finance costs jumped 76.5% on higher US$ rates;
-
relocation gains disappeared;
-
a HK$106m withholding tax arose on PRC dividend upstreaming.
FY2024–H1 2026: structural loss phase: With the market stable, Ju Teng lost share of PRC-located casing demand because ODMs moved notebook assembly to Southeast Asia. Revenue fell 13.1% in FY2024. Gross margin dropped to 2.9% and PP&E impairments reached HK$304m. FY2025 brought partial gross-margin repair (4.7%) as PRC capacity was cut and Vietnam came on line. That was offset by a HK$400m impairment and a swing to FX losses as the RMB appreciated.
H1 2026 is the worst half in the dataset. Revenue fell 5.3% as memory-price-driven PC weakness hit orders. On top of that:
-
HK$510m of idle-capacity cost was reclassified to other expenses;
-
FX losses reached HK$211m;
-
trial-production costs for new products were reclassified into selling expenses, almost doubling them to HK$146.5m;
-
the attributable loss reached HK$813m.
Non-controlling interests absorbed 25% of the H1 2026 loss (HK$267m). This suggests the JV-structured entities, including Vietnam, carry a disproportionate share of losses.
Balance sheet
Sources: FY2022–FY2025 results announcements. NAV per share is as reported by the company. Short-term borrowings in FY2024 and FY2025 include HK$1,020.0m and HK$1,003.4m respectively of syndicated term debt reclassified to current after covenant breaches.
Latest balance sheet, 30 June 2026 (Interim Report 2026):
-
Total assets: HK$9,568.9m.
-
Cash and equivalents: HK$590.8m.
-
Borrowings: HK$2,729.6m in total, of which HK$1,927.6m current and HK$801.9m non-current. The syndicated loan was reclassified back to non-current after the First Amendment.
-
Net debt: HK$2,138.8m; net debt to equity 45.3%.
-
Equity attributable: HK$3,974.0m (NAV per share about HK$3.3). Total equity: HK$4,720.3m.
-
Inventories: HK$1,109.8m. Trade receivables: HK$2,084.6m.
-
Unutilised revolving facilities: HK$855.5m.
Commentary – balance sheet. Management has shrunk the balance sheet by 40% since FY2021:
-
PP&E is down 48% through depreciation running ahead of capex, impairments and land resumptions.
-
Gross debt is down 43% from HK$4.85bn to HK$2.79bn, mainly by working-capital release in FY2022 and land proceeds.
Leverage has not improved because equity has eroded faster: attributable equity is down 35% over FY2021–FY2025 and a further 11% in H1 2026. Net debt to equity has risen from 28.2% (FY2024) to 35.1% (FY2025) and 45.3% (June 2026).
Liquidity headroom is narrowing on every measure:
-
Working capital fell from HK$949m (FY2023) to HK$99m (FY2024) and HK$157m (June 2026).
-
Undrawn revolving facilities fell from HK$1,743m (Dec 2024) to HK$1,142m (Dec 2025) and HK$855m (June 2026).
-
Cash fell from HK$1.03bn to HK$0.59bn over 18 months.
The board's going-concern case rests on three supports (Interim Report 2026, note 1):
-
continued bank rollover;
-
undrawn revolvers;
-
about HK$329m of outstanding land-disposal proceeds still due from purchasers.
Cash flow
Sources: FY2022–FY2025 results announcements, MD&A liquidity sections. Dividends paid are inferred from declared final dividends (HK$96.0m for FY2021, HK$60.0m for FY2022) and are not taken from the cash-flow statement.
H1 2026 cash flow (Interim Report 2026):
-
Operating cash flow: -HK$93.5m.
-
Purchases of PP&E: HK$116.1m, plus HK$48.0m increase in capex prepayments, mainly Vietnam equipment.
-
Net investing: -HK$143.4m.
-
Financing: -HK$94.5m.
-
Net decrease in cash: HK$331.4m.
Commentary – cash flow. Cash generation has been driven by working capital, not earnings:
-
FY2022's HK$2.26bn operating cash flow reflected the unwinding of FY2021 receivables (from HK$4.30bn to HK$2.42bn).
-
FY2024's HK$741m came from cutting inventory by 32%.
-
FY2025 reversed: receivables and inventory rose together (receivable days 153, inventory days 88), turning operating cash flow negative.
-
H1 2026 remained negative despite inventory falling.
Vietnam capex continues while PRC land proceeds are lumpy. Dividends were suspended from FY2023 and no buybacks have been made.
Ratios
Sources: calculated from audited figures. FY2024–FY2025 ROE, net debt to equity, interest coverage and turnover days match company-reported highlights in AR2025 (ROE -10.5% and -10.8%; interest coverage -298.2% and -328.9%). H1 2026 company-reported ratios: annualised ROE -38.8%; interest coverage -1,574.2%; net debt to equity 45.3%; inventory, receivable and payable days 80, 147 and 71.
Commentary – ratios.
-
Returns on capital have been negative for three years. Even the "profitable" FY2021–FY2022 years produced ROE below 3%, well below any reasonable cost of equity.
-
Net debt to EBITDA of 18x (FY2025) and negative interest coverage explain the repeated covenant failures:
-
FY2024: two covenants breached (leverage and interest coverage).
-
FY2025: three covenants breached, cured by the First Amendment, which relaxed tangible-net-worth and gearing tests retroactively.
-
H1 2026: interest-coverage waiver obtained.
-
-
The cash conversion cycle of about 170–180 days is structurally long because ODM customers pay slowly (60–120-day terms, with ageing extending into 4–6 months). This ties up roughly HK$2.4bn in receivables, about 44% of total equity.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Results by Segment and Segment Margins & Growth (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Segment revenue – casings (HKD Mn) | 11,283.0 | 8,255.9 | 6,936.1 | 6,026.3 | 5,731.2 |
Segment revenue YoY growth (%) | 12.5 | -26.8 | -16.0 | -13.1 | -4.9 |
Segment gross profit (HKD Mn) | 1,212.7 | 463.7 | 507.5 | 173.2 | 268.1 |
Segment gross margin (%) | 10.7 | 5.6 | 7.3 | 2.9 | 4.7 |
Segment operating income, company definition (HKD Mn) | 232.2 | -341.9 | -156.5 | -532.5 | -331.0 |
Segment operating margin (%) | 2.1 | -4.1 | -2.3 | -8.8 | -5.8 |
Segment pre-tax income (HKD Mn) | 200.2 | 238.5 | -166.6 | -727.6 | -633.5 |
Contribution to group revenue (%) | 100 | 100 | 100 | 100 | 100 |
Results by Segment and Segment Margins & Growth (%) (Half-Yearly)
| Metric | H1 2024 | H1 2025 | H1 2026 |
|---|---|---|---|
Revenue (HKD Mn) | 2,999.3 | 2,714.7 | 2,571.8 |
Gross profit (HKD Mn) | 199.4 | 72.7 | 63.7 |
Gross margin (%) | 6.6 | 2.7 | 2.5 |
Loss before tax (HKD Mn) | -94.6 | -130.3 | -1,067.0 |
Loss attributable to equity holders (HKD Mn) | -68.7 | -79.1 | -813.1 |
Group Entities
| Subsidiary | Location | Ownership | Function | Source |
|---|---|---|---|---|
Giant Glory International Ltd | — | 100% (indirect) | Group sales contracting entity (counterparty to Wistron and Compal master sales agreements) | AR2025 |
Everyday Computer Components (Suzhou) Co., Ltd (大昶) | Wujiang, Suzhou | 100% (indirect) | Casing production; land partly resumed | AR2025; announcement 12 May 2025 |
Suzhou Dazhi Communication Accessory Co., Ltd | Suzhou | Wholly owned | Plastics, metal moulds, hot stamping, precision parts | AR2025 |
Wujiang Dading Precision Mould Co., Ltd | Wujiang, Suzhou | 100% (indirect) | Moulds; land resumed | FY2023 results |
Compal Precision Module (Jiangsu) Co., Ltd | Jiangsu | Described as wholly owned in AR2025 (originally a 59.28% Compal JV) | Magnesium-aluminium die-casting/thixomolding; automotive and e-bike parts | AR2025; irasia profile |
Juteng Electronic Technology (Taizhou) Co., Ltd | Taizhou, Jiangsu | Wholly owned | Anodized (metal) casings | AR2025 |
Juteng (Neijiang) Communication Accessory Co., Ltd | Neijiang, Sichuan | Wholly owned | Casing production; mould R&D | AR2025 |
Tasun (Chongqing) Electronic Technology / Compal Electronic Technology (Chongqing) | Chongqing | Described as wholly owned in AR2025 | Coating and casing production | AR2025 |
Lian-Yi Precision (Zhongshan) Inc. | Zhongshan, Guangdong | Non-wholly owned (71% at acquisition, Wistron JV) | Plastic casings; land sold Apr 2025, three-year leaseback-style occupancy | AR2025; announcement 16 Apr 2025 |
Ju Teng Electronic Technology (Vietnam) Ltd | Nghe An Province, Vietnam | Non-wholly owned | New production base; production started Q2 2025 | AR2025; FY2022 results |
Mindforce Holdings Ltd | — | Non-wholly owned (Wistron substantial shareholder) | Holding vehicle for Wistron JVs | AR2025 |
Wah Yuen Technology Holding Ltd | — | Non-wholly owned (Compal substantial shareholder) | Holding vehicle for Compal JVs | AR2025 |
Taiwan (ROC) entities | Taiwan | Various | To be reorganised or disposed under the Lens SPA (Condition Precedent 5) | Joint Announcement 18 May 2026 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 11,283.0 | 8,255.9 | 6,936.1 | 6,026.3 | 5,731.2 |
Cost of sales (HKD Mn) | -10,070.3 | -7,792.2 | -6,428.6 | -5,853.1 | -5,463.1 |
Gross profit (HKD Mn) | 1,212.7 | 463.7 | 507.5 | 173.2 | 268.1 |
Other income and gains (HKD Mn) | 180.2 | 1,094.0 | 279.6 | 301.5 | 356.3 |
Selling and distribution expenses (HKD Mn) | -224.2 | -170.0 | -146.0 | -149.3 | -160.4 |
Administrative expenses (HKD Mn) | -756.3 | -635.6 | -518.0 | -556.4 | -438.7 |
Operating income, company definition (HKD Mn) | 232.2 | -341.9 | -156.5 | -532.5 | -331.0 |
Other expenses (HKD Mn) | -148.5 | -392.0 | -75.1 | -313.8 | -511.1 |
Finance costs (HKD Mn) | -63.8 | -121.6 | -214.6 | -182.7 | -147.7 |
EBIT, PBT plus finance costs (HKD Mn) | 264.0 | 360.1 | 47.9 | -544.8 | -485.8 |
Depreciation of PP&E (HKD Mn) | 1,053.5 | 1,001.3 | 812.3 | 654.8 | 573.4 |
Depreciation of right-of-use assets (HKD Mn) | 18.0 | 23.8 | 21.8 | 20.0 | 17.9 |
EBITDA, PBT plus finance costs plus D&A (HKD Mn) | 1,335.5 | 1,385.2 | 882.1 | 129.9 | 105.5 |
Pre-tax income (HKD Mn) | 200.2 | 238.5 | -166.6 | -727.6 | -633.5 |
Income tax (HKD Mn) | -142.6 | -180.4 | -162.2 | -2.3 | -31.6 |
Profit/(loss) for the year (HKD Mn) | 57.5 | 58.1 | -328.8 | -729.9 | -665.1 |
Attributable to non-controlling interests (HKD Mn) | -104.8 | -114.0 | -98.0 | -200.0 | -171.6 |
Net income attributable to shareholders (HKD Mn) | 162.4 | 172.1 | -230.8 | -529.9 | -493.4 |
EPS basic (HK cents) | 19.2 | 20.4 | -27.3 | -62.7 | -58.3 |
EPS diluted (HK cents) | 19.1 | 20.4 | -27.3 | -62.7 | -58.3 |
Final dividend per share declared (HK cents) | 8 | 5 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 10.7 | 5.6 | 7.3 | 2.9 | 4.7 |
Operating margin, company definition (%) | 2.1 | -4.1 | -2.3 | -8.8 | -5.8 |
EBITDA margin (%) | 11.8 | 16.8 | 12.7 | 2.2 | 1.8 |
Pre-tax margin (%) | 1.8 | 2.9 | -2.4 | -12.1 | -11.1 |
Net margin, attributable (%) | 1.4 | 2.1 | -3.3 | -8.8 | -8.6 |
Revenue YoY growth (%) | 12.5 | -26.8 | -16.0 | -13.1 | -4.9 |
Key Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Impairment of PP&E (HKD Mn) | 0 | -285.4 | -45.0 | -303.6 | -400.0 |
Impairment of goodwill (HKD Mn) | 0 | -52.5 | 0 | 0 | 0 |
Gains on disposal / relocation of PP&E and held-for-sale assets (HKD Mn) | -6.5 | 525.4 | -3.3 | 55.2 | 228.0 |
Net foreign exchange gain/(loss) (HKD Mn) | -132.8 | 394.9 | 111.8 | 145.1 | -105.0 |
Inventory provision (HKD Mn) | 19.5 | -108.2 | 40.5 | -104.8 | -89.3 |
Government subsidy income (HKD Mn) | 93.4 | 121.5 | 38.3 | 19.3 | 17.0 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 17,249.0 | 14,190.0 | 12,156.0 | 10,342.5 | 10,346.5 |
Property, plant and equipment (HKD Mn) | 8,169.9 | 6,587.8 | 5,679.6 | 4,819.4 | 4,255.2 |
Right-of-use assets (HKD Mn) | 685.8 | 887.4 | 807.2 | 721.8 | 696.8 |
Inventories (HKD Mn) | 2,620.1 | 2,193.7 | 1,538.6 | 1,048.3 | 1,317.8 |
Trade receivables (HKD Mn) | 4,297.4 | 2,420.9 | 2,486.4 | 2,118.0 | 2,407.7 |
Cash and cash equivalents (HKD Mn) | 848.6 | 1,706.8 | 1,221.9 | 1,028.4 | 892.4 |
Pledged / restricted bank balances (HKD Mn) | 74.7 | 102.7 | 111.9 | 107.0 | 100.5 |
Short-term borrowings (HKD Mn) | 3,554.6 | 3,048.7 | 2,539.1 | 2,632.9 | 2,765.4 |
Long-term borrowings (HKD Mn) | 1,298.1 | 994.4 | 597.5 | 7.5 | 24.0 |
Total debt (HKD Mn) | 4,852.7 | 4,043.1 | 3,136.6 | 2,640.4 | 2,789.4 |
Net debt, total debt less cash and equivalents (HKD Mn) | 4,004.1 | 2,336.3 | 1,914.8 | 1,612.0 | 1,897.0 |
Trade and bills payables (HKD Mn) | 1,333.0 | 822.6 | 890.8 | 824.4 | 952.6 |
Equity attributable to shareholders (HKD Mn) | 6,842.1 | 6,038.4 | 5,465.4 | 4,637.2 | 4,475.8 |
Non-controlling interests (HKD Mn) | 1,705.6 | 1,404.9 | 1,291.3 | 1,077.1 | 924.7 |
Total equity (HKD Mn) | 8,547.7 | 7,443.3 | 6,756.8 | 5,714.3 | 5,400.5 |
Goodwill and intangibles (HKD Mn) | 52.5 | 0 | 0 | 0 | 0 |
Working capital, net current assets (HKD Mn) | 913.9 | 1,029.7 | 948.9 | 98.9 | 161.6 |
NAV per share attributable (HKD) | 5.7 | 5.0 | 4.6 | 3.9 | 3.7 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) | 709 | 2,256 | 598 | 741 | -135 |
Net cash used in investing activities (HKD Mn) | -1,057 | -491 | -112 | -332 | -127 |
FCF proxy, OCF plus net investing (HKD Mn) | -348 | 1,765 | 486 | 409 | -262 |
Net cash from/(used in) financing activities (HKD Mn) | 252 | -836 | -962 | -585 | 94 |
Dividends paid to shareholders, prior-year final (HKD Mn) | — | 96.0 | 60.0 | 0 | 0 |
Share buybacks (HKD Mn) | — | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, attributable / avg attributable equity (%) | 2.4 | 2.7 | -4.0 | -10.5 | -10.8 |
ROA, profit for year / avg total assets (%) | 0.3 | 0.4 | -2.5 | -6.5 | -6.4 |
ROIC pre-tax, EBIT / (total equity + net debt) (%) | 2.1 | 3.7 | 0.6 | -7.4 | -6.7 |
Current ratio (x) | 1.13 | 1.18 | 1.20 | 1.02 | 1.03 |
Debt to equity, total debt / total equity (x) | 0.57 | 0.54 | 0.46 | 0.46 | 0.52 |
Net debt to equity (%) | 46.8 | 31.4 | 28.3 | 28.2 | 35.1 |
Net debt to EBITDA (x) | 3.0 | 1.7 | 2.2 | 12.4 | 18.0 |
Interest coverage, EBIT / finance costs (x) | 4.1 | 3.0 | 0.2 | -3.0 | -3.3 |
Asset turnover, revenue / avg total assets (x) | 0.65 | 0.53 | 0.53 | 0.54 | 0.55 |
Inventory days (company) | 95 | 103 | 87 | 66 | 88 |
Receivable days (company) | 139 | 107 | 131 | 129 | 153 |
Payable days (company) | 48 | 39 | 51 | 52 | 64 |
Cash conversion cycle (days) | 186 | 171 | 167 | 143 | 177 |
Revenue by Region and Revenue by Region (%)
| Region (delivery location) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
PRC, excluding Hong Kong (HKD Mn) | 11,076.1 | 7,942.9 | 6,495.2 | 5,417.1 | 4,952.2 |
Taiwan / ROC (HKD Mn) | 95.0 | 104.6 | — | — | — |
Others, ex-ROC where separately shown (HKD Mn) | 111.8 | 208.5 | — | — | — |
Total outside PRC (HKD Mn) | 206.9 | 313.0 | 440.9 | 609.2 | 779.0 |
PRC share of revenue (%) | 98.2 | 96.2 | 93.6 | 89.9 | 86.4 |
Outside-PRC share of revenue (%) | 1.8 | 3.8 | 6.4 | 10.1 | 13.6 |
Region growth
| Region growth | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
PRC revenue YoY (%) | -28.3 | -18.2 | -16.6 | -8.6 |
Outside-PRC revenue YoY (%) | 51.3 | 40.9 | 38.2 | 27.9 |
Revenue by Region
| Region | H1 2025 | H1 2026 |
|---|---|---|
PRC (HKD Mn) | 2,401.5 | 1,973.5 |
Vietnam (HKD Mn) | 24.9 | 266.2 |
Others (HKD Mn) | 288.3 | 332.1 |
Total (HKD Mn) | 2,714.7 | 2,571.8 |
Locations
| Location | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
PRC (HKD Mn) | 8,762.6 | 7,065.6 | 6,031.4 | 4,952.1 | 4,223.9 |
Vietnam (HKD Mn) | 0 | 272.0 | 308.0 | 610.3 | 935.7 |
Taiwan / ROC (HKD Mn) | 187.7 | 164.0 | 153.0 | 142.7 | 152.8 |
Others (HKD Mn) | 1.2 | 16.5 | 2.4 | 1.0 | 8.9 |
Share Price History
| Date | Price | Context | Source |
|---|---|---|---|
3 Nov 2005 | 1.40 | IPO issue price (as reported by data vendor) | Data vendor |
~30 Apr – 2 May 2025 | 1.32–1.36 | Pre-results trading | Data vendor snapshot |
11 Dec 2025 | 1.62 | Six-month low before offer period | Joint Announcement |
21 Apr 2026 | 3.18 | Undisturbed date | Joint Announcement |
22 Apr 2026 | 4.05 | Last trading day before halt | Joint Announcement |
20 Jul 2026 | ~2.83 | Reference price in CITIC derivative dealing | Rule 22 disclosure |
3 Aug 2026 | 2.93 | Market quote | Data aggregator |
25 Sep 2026 | 2.32 | Latest close retrieved; 52-week range 1.15–5.52 | Data aggregator |
Valuation Snapshot
| Metric | Value | Basis |
|---|---|---|
Market cap (all issued shares) | HK$2,784m | 1,200.0m shares × HK$2.32 |
Market cap (ex-trust shares) | HK$1,962m | 845.66m shares × HK$2.32 |
Enterprise value | ~HK$5,669m | Market cap HK$2,784m + debt HK$2,730m − cash HK$591m + NCI HK$746m |
TTM revenue | HK$5,588m | FY2025 − H1 2025 + H1 2026 |
TTM EBITDA | ~-HK$934m | FY2025 HK$105.5m − H1 2025 HK$279m + H1 2026 -HK$760m |
P/E | Not meaningful (loss-making) | — |
EV/EBITDA | Not meaningful (negative EBITDA) | — |
EV/Sales | ~1.0x | EV ÷ TTM revenue |
P/B | ~0.70x | HK$2.32 ÷ NAV per share HK$3.31 (HK$3,974m ÷ 1,200.0m shares) |
Offer price vs NAV | 0.59x FY2025 NAV; ~0.66x June 2026 NAV | HK$2.20 ÷ HK$3.73 and HK$3.31 |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Final DPS declared (HK cents) | 8 | 5 | 0 | 0 | 0 |
Final dividend amount declared (HKD Mn) | 96.0 | 60.0 | 0 | 0 | 0 |
Capital Markets
| Bucket | 31 Dec 2025 (HKD Mn) | 30 Jun 2026 (HKD Mn) |
|---|---|---|
Current (≤1 year, including reclassified syndicated debt at Dec 2025) | 2,765.4 | 1,927.6 |
Non-current | 24.0 | 801.9 |
Total | 2,789.4 | 2,729.6 |
of which US$-denominated | 2,477 | 2,283 |
of which MYR Bn-denominated | 290 | 435 |
of which NT$-denominated | 22 | 12 |
Analyst Conclusions
Management guidance. None quantitative. Management is "prudently optimistic" on the long-term PC cycle:
Supports cited: the Windows 11 migration (about 28% of the base still on Windows 10) and AI PC penetration (IDC: 50m GenAI PCs in 2026).
Risks flagged: memory-driven cost inflation, tariff uncertainty and weak visibility.
Operational priorities:
-
consolidate PRC factories;
-
ramp Vietnam;
-
push high-end metal casings;
-
review asset-optimisation plans.
Consensus growth expectations: No sell-side coverage. No consensus is available.
Bull case:
-
The Lens deal effectively sets a floor and brings a strong sponsor.
-
PRC and Vietnam antitrust clearance (7 Oct 2026) removes the largest regulatory hurdle.
-
Once the SPA completes, the trust's tender obligation all but secures control.
-
Lens, with RMB74bn of revenue and a HK$3bn facility, could refinance the group, end covenant stress and steer its own customer programmes into Ju Teng's Vietnam and PRC capacity.
-
-
Operating leverage works in reverse.
-
About HK$573m of annual depreciation and HK$510m of half-year idle cost mean modest volume recovery, from Windows refresh and Vietnam ramp, could swing gross margin back towards FY2023's 7.3%.
-
Vietnam revenue has already grown about tenfold year on year.
-
-
Land monetisation supports book value.
-
Expected gains of about RMB322.5m (Dachang II, by Mar 2027) and about RMB108m (Zhongshan), plus HK$329m of outstanding proceeds, provide non-operating cash and equity support.
-
The stock trades at about 0.7x book.
-
Bear case:
-
The economics keep deteriorating.
-
The H1 2026 loss (HK$813m) exceeded all of FY2025.
-
Attributable equity fell 11% in six months to HK$3.97bn.
-
Gross margin of 2.5% shows the PRC asset base cannot earn its cost of capital even before FX shocks. Further impairments are likely.
-
-
Deal renegotiation or failure risk is real, and the offer offers little.
-
The long-stop has already slipped to 18 Jan 2027, with the Taiwan carve-out and vendor-warranty issues unresolved and Lens "in discussions" with the vendors after a sharply worse H1.
-
Even if the deal completes, HK$2.20 is about 5% below the 25 Sep market price and 34–41% below NAV. Minority holders gain no premium.
-
The acquirer itself swung to a Q1 2026 loss (RMB150m), which could temper its appetite.
-
-
Liquidity is thinning.
-
Cash is HK$591m against HK$1.93bn of current borrowings.
-
Undrawn revolvers have halved in 18 months to HK$855m.
-
Covenants have been breached or waived in each of the last three test periods. Without completion, the group depends on bank forbearance and lumpy land proceeds.
-
Key catalysts and monitorables (next 12 months):
-
NDRC approval and SAFE filing (CP8); Taiwan reorganisation (CP5); vendor-warranty resolution (CP17); SPA completion before 18 Jan 2027; composite document by 23 Jan 2027.
-
The IBC and Somerley's fairness opinion on HK$2.20 against NAV.
-
Renewal of the Wistron and Compal master sales agreements, which expire 31 Dec 2026.
-
31 Dec 2026 covenant test, and any refinancing under Lens.
-
FY2026 results (expected March 2027): size of further PP&E impairment; whether the Dachang II gain is recognised (vacate by 30 Mar 2027).
-
Vietnam utilisation and revenue share; whether PRC idle-capacity charges continue.
-
RMB/US$ path, which drives FX losses on US$ receivables.
-
Board reconstitution with Lens nominees; any asset injections or disposals after completion.
-
Follow-up on the January 2026 cyber incident, including client attrition.
Concluding analyst verdict. Ju Teng has become a special-situation asset rather than an operating-recovery story. The fundamentals are poor and getting worse:
-
Revenue has halved since FY2021.
-
Gross margin has fallen from double digits to 2.5%.
-
Three straight annual losses have been followed by an H1 2026 loss larger than any prior full year.
-
Liquidity buffers are shrinking while covenants are repeatedly waived.
The core problem is geographic. Ju Teng's largely PRC asset base is being stranded as notebook ODMs move assembly to Southeast Asia, and the Vietnam plant is too new and too small to absorb that shift. Impairments and idle-capacity charges are the accounting expression of that mismatch, and they are not yet finished.
Against that, the Lens Technology transaction now dominates the equity story. With antitrust clearances in hand and the share-award trust obliged to tender, completion would almost certainly hand Lens control. It would give Ju Teng a deep-pocketed industrial owner able to refinance it and to redirect volume into its plants. For creditors, employees and the group's long-term viability, this is clearly positive.
For minority shareholders the picture is far less attractive:
-
The HK$2.20 offer price is below the current market and at roughly 0.6–0.7x book.
-
Lens intends to keep the listing, so non-accepting holders would become minorities in a loss-making subsidiary with no dividend.
-
Completion still depends on PRC outbound approvals, a Taiwan carve-out and vendor-warranty negotiations that began after the H1 deterioration. Repricing or delay cannot be ruled out.
Our assessment:
Ju Teng's standalone credit and operating profile: high-risk. Near-term direction depends on the deal.
Equity: limited upside at prevailing prices. The offer caps near-term value, while failure would expose the weak standalone balance sheet.
What to watch: the IBC/IFA recommendation and the 31 December 2026 covenant test.
Prepared from public filings and market data available as of 11 October 2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Age (AR2025) | Background / education | Source |
|---|---|---|---|---|---|
Cheng Li-Yu (鄭立育) | Chairman, CEO, executive director | ED since 15 Jul 2004; CEO since 16 Mar 2022 | 67 | Co-founder; began career around 1984 at San Li Industrial (spray painting); younger brother of Cheng Li-Yen | AR2025 |
Chiu Hui-Chin (邱輝欽) | Executive director, Chief Strategy Officer | 1 Mar 2017 (CEO 2017–2022) | 72 | Former CEO of Lite-On Technology; MSc Industrial Engineering (NTUT); EMBA (NTU); independent director of Syncmold, Integrated Service Technology, Auras and Amia | AR2025 |
Huang Kuo-Kuang (黃國光) | Executive director (procurement and operations) | Joined Feb 2001; ED since 10 Jun 2005 | 65 | Over 33 years in computer industry; senior vice president of Everyday Computer and Suzhou Dazhi since 2002 | AR2025 |
Tsui Yung Kwok (徐容國) | Executive director, CFO | Joined Aug 2004; ED since 10 Jun 2005 | 57 | CA ANZ, CPA Australia, HKICPA, HKCGI; INED of Shenguan, Cabbeen and Intron Technology | AR2025 |
Wang Ting Jin (王挺進) | Executive director | 11 Jun 2025 | 57 | General manager of Lens Technology ODM business operations (May 2024–Mar 2025); general manager of Lens Changsha (2023–2024); Apple procurement and manufacturing design roles (2008–2021) in laptop casings and brittle materials; Sanmina; BEng Tsinghua; MASc Toronto | AR2025 |
Cheng Li-Yen (鄭立彥) | Non-executive director | NED since 16 Mar 2022 (ED 2005–2017) | 72 | Co-founder; elder brother of the chairman; beneficiary of the Cheng Family Trust | AR2025 |
Yip Wai Ming (葉偉明) | INED; chair of Corporate Governance Committee | 25 May 2006 | 60 | HKICPA, FCCA; INED of PAX Global, Far East Horizon, Sinohope and Peijia Medical | AR2025 |
Yuen Chi Ho (袁志豪) | INED; chair of Audit and Remuneration Committees | 6 Dec 2022 | 58 | FCCA, HKICPA; former CFO and COO of IPE Group | AR2025 |
Dr. Chuang Shu-Hui (莊淑惠) | INED | 2 Sep 2024 | 60 | Chair of the Department of Business Administration, Asia University (Taiwan); PhD in Information Management; independent director of Bai Sha Technology | AR2025 |
Directors' Remuneration
| Item | Value | Source |
|---|---|---|
Cheng Li-Yu remuneration as director, FY2025 | HK$888,000 | Joint Announcement 18 May 2026 |
Key management personnel short-term benefits, H1 2026 | HK$5.2m (H1 2025: HK$6.127m) | Interim Report 2026, note 18 |
Senior management pay bands, FY2025 (10 persons) | 7 at HK$0.5–1.0m; 2 at HK$1.0–1.5m; 1 at HK$1.5–2.0m | AR2025 |
Discretionary management bonus | Introduced for Cheng Li-Yu, Chiu, Huang and Tsui with effect from 11 Jun 2025 | AR2025 |
Share-based awards | No options outstanding; no share awards granted, vested or outstanding in FY2025 or H1 2026 | AR2025; Interim Report 2026 |
Proposed post-deal arrangement | Cheng Li-Yu to act as consultant for three years after completion, at no more than HK$888,000 a year | Joint Announcement 18 May 2026 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
16 Mar 2022 | Cheng Li-Yu becomes chairman and CEO; Chiu Hui-Chin moves to CSO; Cheng Li-Yen joins as NED | Founder re-assumed operating control |
6 Dec 2022 | Yuen Chi Ho appointed INED | Board refresh |
16 May 2024 | INED Tsai Wen-Yu retires | FY2024 results |
2 Sep 2024 | Dr. Chuang Shu-Hui appointed INED | Board refresh |
28 May 2025 | Executive director Lin Feng-Chieh and INED Cherng Chia-Jiun retire | AGM |
11 Jun 2025 | Wang Ting Jin, ex-Lens ODM general manager, appointed executive director | Arrived about 11 months before the Lens SPA; in hindsight an early signal of the relationship |
After Lens completion | Lens intends to nominate new directors; Cheng Li-Yu to become consultant | Joint Announcement 18 May 2026 |
Major Shareholders
| Holder | Shares | % | Notes | Source |
|---|---|---|---|---|
Bank of Communications Trustee Ltd (Share Award Plan trustee) | 354,345,774 | 29.53 | Abstains from voting under the 2022 amendment; has undertaken to accept the Lens offer (CP2) | Interim Report 2026; Joint Announcement |
Southern Asia Management Ltd (Cheng Family Trust) | 303,240,986 | 25.27 | Vendor under the Lens SPA | Interim Report 2026 |
Cheng Li-Yu (personal) | 23,408,000 | 1.95 | Vendor | Interim Report 2026 |
Lin Mei-Li (spouse of the chairman) | 7,064,046 | 0.59 | Vendor | Interim Report 2026 |
Lens Technology Co., Ltd (deemed, conditional) | 333,713,032 | 27.81 | Through the SPA; ultimately controlled by Ms. Chau Kwan Fei (周群飛) | Interim Report 2026 |
Huang Kuo-Kuang (with spouse) | 10,586,497 | 0.88 | Director | Interim Report 2026 |
Tsui Yung Kwok | 6,156,000 | 0.51 | Director | Interim Report 2026 |
Chiu Hui-Chin | 5,082,000 | 0.42 | Down from 5,900,000 (0.49%) at 31 Dec 2025, i.e. about 818,000 shares disposed in H1 2026 | AR2025; Interim Report 2026 |
Other public shareholders | 511,949,639 | 42.66 | Includes TDR holders (144.3m shares) | Joint Announcement 18 May 2026 |
Competitive Landscape
Key Competitors
| Competitor | HQ / listing | Segment overlap | Latest revenue (as verified) | Relative positioning | Source / verification |
|---|---|---|---|---|---|
Catcher Technology | Taiwan (2474.TW) | Aluminium and magnesium notebook upper/lower cases, keyboard covers, server and desktop casings | FY2025 NT$18.66bn (+3.2%), growth driven by medtech | Historic metal-casing leader; sold its main China smartphone-casing plants to Lens in 2020; cash-rich and diversifying | Catcher AGM 2026 business report |
Lens Technology | China (300433.SZ / 6613.HK) | Structural components, metal casings, device assembly; acquirer of Ju Teng | FY2025 RMB74.41bn (+6.46%); net profit RMB4.02bn; Q1 2026 revenue -17.13%, net loss RMB150m | Scale leader in glass and precision structures; moving into PC casings via Ju Teng | Press reports of Lens filings |
Foxconn / Hon Hai precision-mechanics units | Taiwan / China | In-house and third-party mechanical enclosures | — | Vertically integrated; captive volumes | — |
BYD Electronic | Hong Kong (285.HK) | Metal and plastic structural parts, assembly | — | Large Chinese precision-structure platform | — |
Waffer Technology | Taiwan (6235.TWO) | Notebook chassis (magnesium, aluminium) | — | Niche magnesium-alloy specialist | DigiTimes (historical) |
Casetek / Pegatron mechanical units | Taiwan | Metal notebook and tablet casings | — | Captive to the Pegatron ecosystem | — |
Everwin Precision | China (300115.SZ) | Precision structural parts and casings | — | Chinese competitor in metal structures | — |
Tongda Group | Hong Kong (698.HK) | Casings for handsets and notebooks | — | Smaller HK-listed peer | — |
ODM in-house mechanical divisions (Compal, Wistron, Quanta) | Taiwan | Some internal casing capability | — | Partners and potential substitutes | — |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric | Ju Teng FY2025 | Lens Technology FY2025 | Catcher FY2025 |
|---|---|---|---|
Revenue (local currency, bn) | HK$5.73 | RMB74.41 | NT$18.66 |
Revenue growth (%) | -4.9 | 6.5 | 3.2 |
Gross margin (%) | 4.7 | — | — |
Net margin (%) | -8.6 | 5.4 (calculated) | — |
Recent Developments
*Layoffs and hiring: Headcount fell from about 22,600 in H1 2025 to about 21,000 in H1 2026, and from about 38,000 in FY2021 to about 21,000 in FY2025.



